Post transplant diabetes mellitus: Advances and innovations

Title : Post transplant diabetes mellitus: Advances and innovations

Abstract:

Solid organ transplantation, via multiple mechanisms, accentuates pre-existing diabetes mellitus and promotes de novo diabetes post-transplant. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel, emerging diabetes treatments. There is a growing body of evidence supporting safe and effective use, particularly in kidney transplantation. The aim of this talk is to describe significance of post-transplant diabetes, highlight evidence supporting use of SGLT2i and GLP-1 RA, and provide guidance for clinical application.

Biography:

Dr. Swanson studied Biology at St. Olaf College, USA and graduated as BA in 2011. He received his MD degree in 2015 from the University of Iowa. He completed residency at the Medical College of Wisconsin in 2018. He went on to complete his nephrology and transplant nephrology fellowships at the University of Wisconsin-Madison in 2021. He then joined the University of Minnesota as assistant professor until 2022.  He returned to UW-Madison as an assistant professor, his current position. He has an H-index of 10. He enjoys spending time with his wife Kimberley and daughters Junie and Viola.